775 results on '"Siest, Gérard"'
Search Results
52. Cardiovascular risk-associated allele frequencies for 15 genes in healthy elderly French and Chinese
53. Second Santorini Conference “From Human Genetic Variations to Prediction of Risks and Responses to Drugs and to the Environment”
54. A Prospective Study on the Prevalence of Metabolic Syndrome Among Healthy French Families: Two cardiovascular risk factors (HDL cholesterol and tumor necrosis factor-α) are revealed in the offspring of parents with metabolic syndrome
55. Phenotypic sensitivity to activated protein C in healthy families: importance of genetic components and environmental factors
56. Age- and sex-related reference values for serum insulin concentration and its biological determinants in a French healthy population. The STANISLAS cohort
57. Study of reference values and biological variation: a necessity and a model for Preventive Medicine Centers
58. Immobilization of microsomes into alginate beads is a convenient method for producing glucuronides from drugs
59. Family study of the relationship between height and cardiovascular risk factors in the STANISLAS cohort
60. Serum Total Antioxidant Status, Erythrocyte Superoxide Dismutase and Whole-Blood Glutathione Peroxidase Activities in the Stanislas Cohort: Influencing Factors and Reference Intervals
61. Pharmacogenomics of Drugs Affecting the Cardiovascular System
62. PON1-192 Phenotype and Genotype Assessments in 918 Subjects of the Stanislas Cohort Study
63. First Santorini Conference: From Genetic Variations to Risk Prediction and Pharmacogenomics
64. Time-dependent lipid response on fluvastatin therapy of patients with hypercholesterolemia sensitive to apoE phenotype
65. Homo- and hetero-complexes of exchangeable apolipoproteins in solution and in lipid-bound form
66. Charge-based heterogeneity of human plasma lipoproteins at hypertriglyceridemia: capillary isotachophoresis study
67. Myeloperoxidase polymorphisms in brain infarction. Association with infarct size and functional outcome
68. IL-6, TNF-α and atherosclerosis risk indicators in a healthy family population: the STANISLAS cohort
69. Wine, Beer, and Mortality in Middle-aged Men From Eastern France
70. Lipid Free Apolipoprotein E Binds to the Class B Type I Scavenger Receptor I (SR-BI) and Enhances Cholesteryl Ester Uptake from Lipoproteins
71. Apolipoprotein E Activates Akt Pathway in Neuro-2a in an Isoform-Specific Manner
72. Early-glycation of apolipoprotein E: effect on its binding to LDL receptor, scavenger receptor A and heparan sulfates
73. Rapid spectrophotometric method for serum glutathione S-transferases activity
74. γ-Glutamyltranspeptidase-Dependent Metabolism of 4-Hydroxynonenal–Glutathione Conjugate
75. Increased protein glycation in cerebrospinal fluid of Alzheimer’s disease
76. Protein–lipid interactions in reconstituted high density lipoproteins: apolipoprotein and cholesterol influence
77. Pharmacogenomics and Theranostics in Practice
78. Reconstituted Epidermis: A Novel Model for the Study of Drug Metabolism in Human Epidermis
79. Structural peculiarities of the binding of very low density lipoproteins and low density lipoproteins to the LDL receptor in hypertriglyceridemia: role of apolipoprotein E
80. Conformation of apolipoprotein E both in free and in lipid-bound form may determine the avidity of triglyceride-rich lipoproteins to the LDL receptor: structural and kinetic study
81. Evidence for the pro-oxidant effect of γ-glutamyltranspeptidase–related enzyme
82. Differential oxidation of apolipoprotein E isoforms and interaction with phospholipids
83. Characterization and quantification of serum lipoprotein subfractions by capillary isotachophoresis: relationships with lipid, apolipoprotein, and lipoprotein levels
84. Glycation of apolipoprotein E impairs its binding to heparin: identification of the major glycation site
85. Next generation sequencing and immuno-histochemistry profiling identify numerous biomarkers for personalized therapy of endometrioid endometrial carcinoma
86. Epistatic study reveals two genetic interactions in blood pressure regulation
87. Immobilization of epoxide hydrolase purified from rat liver microsomes
88. De l’écogénétique à la pharmacogénomique par le stress oxydant
89. La Pharmacogénomique, meilleur exemple de médecine personnalisée
90. Progress in pharmacogenetics: consortiums and new strategies
91. Systems medicine, personalized health and therapy
92. Genetic determined low response to thienopyridines is associated with higher systemic inflammation in smokers
93. Présent et futur de la protéomique clinique
94. Drug Effect in Clinical Chemistry - Information and Education
95. Laboratory Tests and Drug Effects: Usefulness of a Data Bank
96. RATE OF GLUCURONOCONJUGATION OF PHENOLIC SUBSTRATES AND METABOLITES
97. Contribution of Health-Testing Centers to Reference Values Determination
98. LIST OF PARTICIPANTS
99. Next generation sequencing and immunohistochemistry profiling identify numerous biomarkers for personalized therapy of endometrioid endometrial carcinoma.
100. From DMDI “Drug Metabolism and Drug Interactions” to DMPT “Drug Metabolism and Personalized Therapy”
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.